APA (7th ed.) Citation

Schmidt, R., Rueger, C., Xu, H., He, Y., Yilmaz, E. Y., Heidemann, L., . . . Savic, L. J. (2025). Comparing the Prognostic Value of Quantitative Response Assessment Tools and LIRADS Treatment Response Algorithm in Patients with Hepatocellular Carcinoma Following Interstitial High-Dose-Rate Brachytherapy and Conventional Transarterial Chemoembolization. Cancers, 17(8), 1275. https://doi.org/10.3390/cancers17081275

Chicago Style (17th ed.) Citation

Schmidt, Robin, et al. "Comparing the Prognostic Value of Quantitative Response Assessment Tools and LIRADS Treatment Response Algorithm in Patients with Hepatocellular Carcinoma Following Interstitial High-Dose-Rate Brachytherapy and Conventional Transarterial Chemoembolization." Cancers 17, no. 8 (2025): 1275. https://doi.org/10.3390/cancers17081275.

MLA (9th ed.) Citation

Schmidt, Robin, et al. "Comparing the Prognostic Value of Quantitative Response Assessment Tools and LIRADS Treatment Response Algorithm in Patients with Hepatocellular Carcinoma Following Interstitial High-Dose-Rate Brachytherapy and Conventional Transarterial Chemoembolization." Cancers, vol. 17, no. 8, 2025, p. 1275, https://doi.org/10.3390/cancers17081275.